Product image of Levetiracetam Altan (Levetiracetam) supplied by GNH India

Levetiracetam Altan

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Altan (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Altan, is an anticonvulsant presented as an intravenous solution for intravenous use. It is employed to control various seizure types in patients diagnosed with epilepsy.
GNH India supplies Levetiracetam Altan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Altan Pharma Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levetiracetam is an antiepileptic agent that modulates neuronal excitability to reduce seizure activity.

  • Partial‑onset seizures: helps achieve seizure control in focal epilepsy.
  • Generalized tonic‑clonic seizures: contributes to reduction of convulsive episodes.
  • Myoclonic seizures: assists in decreasing sudden muscle jerks associated with this seizure type.

How It Works

  • Levetiracetam binds to the synaptic vesicle protein SV2A, a key regulator of neurotransmitter release. This interaction modulates synaptic vesicle exocytosis, leading to reduced neuronal hyper‑excitability and stabilization of neuronal firing patterns, which underlies its antiepileptic effect.

Side Effects

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Dizziness: transient sensation of light‑headedness.
  • Fatigue: generalized feeling of tiredness.
  • Headache: mild to moderate cranial pain.
  • Somnolence: increased sleepiness or drowsiness.

Serious or Rare Side Effects

  • Severe allergic reactions: rash, swelling, or anaphylaxis.
  • Stevens‑Johnson syndrome: rare but serious skin disorder.
  • Suicidal thoughts or behavior: emergence of mood changes or depressive symptoms.

Precautions & Warnings

Before initiating therapy, clinicians should consider several safety aspects.

  • Renal function monitoring: adjust dose in patients with impaired clearance.
  • Psychiatric assessment: watch for mood changes or suicidal ideation.
  • Concomitant CNS depressants: avoid excessive sedation.
  • Abrupt discontinuation: taper to prevent seizure worsening.
  • Hepatic disease caution: use with clinical judgment.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Levetiracetam has a relatively low interaction profile, yet certain combinations require attention.

Major Interactions (Avoid)

  • Carbamazepine: may lower levetiracetam plasma concentrations.
  • Phenobarbital: can reduce levetiracetam levels.
  • Phenytoin: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely)

  • Alcohol: may enhance central nervous system depression.
  • Sedative agents (e.g., benzodiazepines): additive sedative effect.
  • Probenecid: may increase levetiracetam levels by reducing renal excretion.

Frequently Asked Questions

Levetiracetam Altan is an intravenous antiepileptic medication indicated for the treatment of partial‑onset seizures, generalized tonic‑clonic seizures, and myoclonic seizures in patients with epilepsy.

Levetiracetam binds to the synaptic vesicle protein SV2A, modulating neurotransmitter release and reducing neuronal hyper‑excitability, which helps prevent the initiation and spread of seizure activity.

The prescribed dose of Levetiracetam Altan is determined by the treating physician based on the patient’s clinical condition, seizure type, renal function, and other individual factors.

Safety data for levetiracetam in pregnancy and lactation are limited. Clinicians should weigh potential benefits against risks and consider alternative therapies when appropriate.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Levetiracetam has a distinct mechanism targeting SV2A and generally exhibits fewer drug‑drug interactions than many enzyme‑inducing antiepileptics, making it a convenient option for patients on multiple medications.

Levetiracetam Altan should be stored at 2‑8 °C, protected from light, and kept in its original container. Do not freeze or shake the solution before administration.

Levetiracetam Altan is given as an intravenous infusion. The rate and duration of infusion are set by the prescriber and should follow institutional protocols for IV medication administration.

Serious risks include severe allergic reactions, Stevens‑Johnson syndrome, and emergence of suicidal thoughts or behavior. Patients should be monitored closely for any signs of these conditions.

Patients with known hypersensitivity to levetiracetam or any component of the formulation should avoid its use. Caution is also advised in individuals with severe renal impairment where dose adjustment may be required.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT